Kite Pharma, Inc. (KITE) has 113 open-market insider trades by 17 insiders since 2015. The most active filer is Cynthia M. Butitta, COO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Farah Champsi | Dir | — | 5 | $86.4M | 2017-10-03 |
| Helen Susan Kim | VP | — | 15 | $31.9M | 2017-10-03 |
| Cynthia M. Butitta | COO | — | 30 | $24.6M | 2017-10-03 |
| David D. Chang | VP | — | 6 | $12.3M | 2017-10-03 |
| Arie Belldegrun | CEOChairmanPres | — | 3 | $11.0M | 2017-10-03 |
| Jeffrey Wiezorek | VP | — | 25 | $8.6M | 2017-10-03 |
| David Bonderman | Dir | — | 1 | $6.9M | 2017-10-03 |
| Timothy L. Moore | VP | — | 3 | $4.7M | 2017-10-03 |
| Roy Doumani | Dir | — | 3 | $4.3M | 2017-10-03 |
| Margo R. Roberts | CSO | — | 6 | $3.0M | 2016-03-15 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Shawn Tomasello | CCO | Sell | $1.5M | 2017-09-25 |
| Jeffrey Wiezorek | VP | Sell | $1.9M | 2017-09-25 |
| David D. Chang | VP | Sell | $2.8M | 2017-09-25 |
| Paul L. Jenkinson | CFO | Sell | $341K | 2017-09-25 |
| Cynthia M. Butitta | COO | Sell | $1.5M | 2017-09-25 |
| Helen Susan Kim | VP | Sell | $1.1M | 2017-09-25 |
Companies that share insiders with KITE, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Arie Belldegrun | CEO & Chairman +1 | Sell | $9.5M | 2017-09-25 |
| Helen Susan Kim | VP | Sell | $1.5M | 2017-08-10 |
| Cynthia M. Butitta | COO | Sell | $1.8M | 2017-08-10 |
| Helen Susan Kim | VP | Sell | $5.2M | 2017-08-08 |
| Helen Susan Kim | VP | Sell | $9.6M | 2017-08-08 |
| Timothy L. Moore | VP | Sell | $1.3M | 2017-08-03 |
| Timothy L. Moore | VP | Sell | $2.5M | 2017-08-01 |
| Helen Susan Kim | VP | Sell | $1.2M | 2017-07-31 |
| Helen Susan Kim | VP | Sell | $2.9M | 2017-07-31 |